YaoGeJu

Company directoryChina company filings

Hybio Pharmaceutical Co.,Ltd.

As of 18 November 2026, for the company name Hybio Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 18 active records with this name as holder; 20 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

36 acceptance records as first applicant, grouped into 15 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

HY3003片 · No verified English name 4 records · Latest accepted 2026/11/04

New drug · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2601367New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601366New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601365New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601364New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003注射液 · No verified English name 6 records · Latest accepted 2026/09/09

New drug · 6

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2601100New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601099New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601098New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601097New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601096New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2601095New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
替尔泊肽注射液 · No verified English name 4 records · Latest accepted 2026/08/06

Generic · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2601926Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗
CYHS2601925Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗
CYHS2601924Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗
CYHS2601923Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗
利拉鲁肽注射液 · No verified English name 2 records · Latest accepted 2024/10/13

New drug · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2400103New drug2024/10/13Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHS2200041New drug2022/07/28Hybio Pharmaceutical Co.,Ltd.CDE ↗
特立帕肽注射液 · No verified English name 1 records · Latest accepted 2024/02/23

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2400015New drug2024/02/23Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name 7 records · Latest accepted 2024/02/02

New drug · 7

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2400138New drug2024/02/02Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2400137New drug2024/02/02Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2400136New drug2024/02/02Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2400135New drug2024/02/02Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2400134New drug2024/02/02Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2300984New drug2023/09/12Hybio Pharmaceutical Co.,Ltd.CDE ↗
CXHL2300983New drug2023/09/12Hybio Pharmaceutical Co.,Ltd.CDE ↗
Carbetocin Injection 1 records · Latest accepted 2023/04/11

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2300765Supplement2023/04/11Hybio Pharmaceutical Co.,Ltd.CDE ↗
Linaclotide Capsules 1 records · Latest accepted 2023/02/18

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2300023Generic2023/02/18Hybio Pharmaceutical Co.,Ltd.CDE ↗
Somatostatin For Injection 1 records · Latest accepted 2022/10/18

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2201914Supplement2022/10/18Hybio Pharmaceutical Co.,Ltd.CDE ↗
Ganirelix Injection 1 records · Latest accepted 2022/09/27

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201612Generic2022/09/27Hybio Pharmaceutical Co.,Ltd.; Nanjing King-Friend Biochemical Pharmaceutical Co., LtdCDE ↗
Desmopressin Acetate Injection 2 records · Latest accepted 2022/04/26

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250240Supplement2022/04/26Hybio Pharmaceutical Co.,Ltd.; Gansu Cheng Ji Bio Pharma Co., Ltd. romanizedCDE ↗
CYHB2250239Supplement2022/04/26Hybio Pharmaceutical Co.,Ltd.; Gansu Cheng Ji Bio Pharma Co., Ltd. romanizedCDE ↗
Exenatide Injection 2 records · Latest accepted 2022/03/21

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2200469Generic2022/03/21Hybio Pharmaceutical Co.,Ltd.CDE ↗
CYHS2200468Generic2022/03/21Hybio Pharmaceutical Co.,Ltd.CDE ↗
特利加压素注射液 · No verified English name 1 records · Latest accepted 2021/10/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101870Generic2021/10/22Hybio Pharmaceutical Co.,Ltd.; Gansu Cheng Ji Bio Pharma Co., Ltd. romanizedCDE ↗
Octreotide Acetate Injection 1 records · Latest accepted 2021/10/19

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101875Generic2021/10/19Hybio Pharmaceutical Co.,Ltd.; Gansu Cheng Ji Bio Pharma Co., Ltd. romanizedCDE ↗
Oxytocin Injection 2 records · Latest accepted 2021/08/24

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150818Supplement2021/08/24Hybio Pharmaceutical Co.,Ltd.; Gansu Cheng Ji Bio Pharma Co., Ltd. romanizedCDE ↗
CYHB2150723Supplement2021/07/12Hybio Pharmaceutical Co.,Ltd.; Gansu Cheng Ji Bio Pharma Co., Ltd. romanizedCDE ↗

Changes in the last 90 days

12 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Marketing application approved: 1 applicationAccepted: 10 applicationsNo longer listed under review: 1 application

  1. 2026/11/10Marketing application approved

    特立帕肽(H)注射液 · No verified English name

    CXHS2400015 · 国药准字H20266535

    Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14

    View source · Table row 2 ↗
  2. 2026/11/04Accepted

    HY3003片 · No verified English name

    CXHL2601367

    Fact date: 2026/11/04 · Date added to this site: 2026/11/05

    View source ↗
  3. 2026/11/04Accepted

    HY3003片 · No verified English name

    CXHL2601366

    Fact date: 2026/11/04 · Date added to this site: 2026/11/05

    View source ↗
  4. 2026/11/04Accepted

    HY3003片 · No verified English name

    CXHL2601365

    Fact date: 2026/11/04 · Date added to this site: 2026/11/05

    View source ↗
  5. 2026/11/04Accepted

    HY3003片 · No verified English name

    CXHL2601364

    Fact date: 2026/11/04 · Date added to this site: 2026/11/05

    View source ↗
  6. 2026/10/24No longer listed under review

    特立帕肽注射液 · No verified English name

    CXHS2400015

    Fact date: 2026/10/24 · Date added to this site: 2026/10/24

    Accepted: 2024/02/23

    no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked

    View source ↗
  7. 2026/09/09Accepted

    HY3003注射液 · No verified English name

    CXHL2601100

    Fact date: 2026/09/09 · Date added to this site: 2026/10/22

    View source ↗
  8. 2026/09/09Accepted

    HY3003注射液 · No verified English name

    CXHL2601099

    Fact date: 2026/09/09 · Date added to this site: 2026/10/22

    View source ↗
  9. 2026/09/09Accepted

    HY3003注射液 · No verified English name

    CXHL2601098

    Fact date: 2026/09/09 · Date added to this site: 2026/10/22

    View source ↗
  10. 2026/09/09Accepted

    HY3003注射液 · No verified English name

    CXHL2601097

    Fact date: 2026/09/09 · Date added to this site: 2026/10/22

    View source ↗
  11. 2026/09/09Accepted

    HY3003注射液 · No verified English name

    CXHL2601096

    Fact date: 2026/09/09 · Date added to this site: 2026/10/22

    View source ↗
  12. 2026/09/09Accepted

    HY3003注射液 · No verified English name

    CXHL2601095

    Fact date: 2026/09/09 · Date added to this site: 2026/10/22

    View source ↗

Under review

14 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
HY3003片 · No verified English name CXHL2601367New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003片 · No verified English name CXHL2601366New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003片 · No verified English name CXHL2601365New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003片 · No verified English name CXHL2601364New drug2026/11/04Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003注射液 · No verified English name CXHL2601100New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003注射液 · No verified English name CXHL2601099New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003注射液 · No verified English name CXHL2601098New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003注射液 · No verified English name CXHL2601097New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003注射液 · No verified English name CXHL2601096New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
HY3003注射液 · No verified English name CXHL2601095New drug2026/09/09Hybio Pharmaceutical Co.,Ltd.CDE ↗
替尔泊肽注射液 · No verified English name CYHS2601926Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗
替尔泊肽注射液 · No verified English name CYHS2601925Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗
替尔泊肽注射液 · No verified English name CYHS2601924Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗
替尔泊肽注射液 · No verified English name CYHS2601923Generic2026/08/06Hybio Pharmaceutical Co.,Ltd.CDE ↗

Catalogue holder records

18 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Ganirelix InjectionHybio Pharmaceutical Co.,Ltd.Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd国药准字H202437972024/05/21Generic approved under the new chemical-drug registration classificationCDE ↗
去氨加压素注射液 · No verified English nameHybio Pharmaceutical Co.,Ltd.Gansu Cheng Ji Bio Pharma Co., Ltd. romanized国药准字H200640942023/09/28Drug that passed quality-and-efficacy consistency evaluationCDE ↗
去氨加压素注射液 · No verified English nameHybio Pharmaceutical Co.,Ltd.Gansu Cheng Ji Bio Pharma Co., Ltd. romanized国药准字H200640932023/09/28Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Oxytocin InjectionHybio Pharmaceutical Co.,Ltd.Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanized国药准字H202370322023/03/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Oxytocin InjectionHybio Pharmaceutical Co.,Ltd.Tai Ji Group Sichuan Tai Ji Pharmaceutical Co., Ltd. romanized国药准字H200531712023/03/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
特利加压素注射液 · No verified English nameHybio Pharmaceutical Co.,Ltd.Gansu Cheng Ji Bio Pharma Co., Ltd. romanized国药准字H202331112023/01/31Generic approved under the new chemical-drug registration classificationCDE ↗
Octreotide Acetate InjectionHybio Pharmaceutical Co.,Ltd.Gansu Cheng Ji Bio Pharma Co., Ltd. romanized国药准字H202330622023/01/19Generic approved under the new chemical-drug registration classificationCDE ↗
Sitagliptin Phosphate and Metformin Hydrochloride Tablets (II)Hybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H202330252023/01/10Generic approved under the new chemical-drug registration classificationCDE ↗
Vildagliptin TabletsHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H202239272022/12/30Generic approved under the new chemical-drug registration classificationCDE ↗
Atosiban Acetate InjectionHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H201933942022/01/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Atosiban Acetate InjectionHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H201933952022/01/07Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Terlipressin for InjectionHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H200938042021/12/22Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Somatostatin For InjectionHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H200452742021/11/02Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Pramipexole Dihydrochloride Prolonged-release TabletsHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H202137522021/09/30Generic approved under the new chemical-drug registration classificationCDE ↗
Eptifibatide InjectionHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H201841172021/08/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Thymalfasin for InjectionHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H201930372021/06/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Carbetocin InjectionHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H201630242021/02/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Metformin Hydrochloride Extended-release TabletsHybio Pharmaceutical Co.,Ltd.Hybio Pharmaceutical Co.,Ltd.国药准字H202033612020/07/29Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

20 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
利拉鲁肽 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20220000540I2022/07/19CDE ↗
胸腺法新 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190009822A2022/10/27CDE ↗
生长抑素 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190009459A2022/10/27CDE ↗
依替巴肽 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190009371A2022/10/27CDE ↗
醋酸特利加压素 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190009359A2022/10/31CDE ↗
醋酸奥曲肽 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190007921A—CDE ↗
硫普罗宁 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190007853A—CDE ↗
卡贝缩宫素 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190006054A2023/03/24CDE ↗
七叶皂苷钠 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190006002A—CDE ↗
醋酸去氨加压素 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190003557A2023/03/24CDE ↗
普罗瑞林 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190002939A—CDE ↗
奥扎格雷 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190002929A—CDE ↗
鲑降钙素 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190002719A2024/01/17CDE ↗
缩宫素溶液 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190002478A—CDE ↗
醋酸曲普瑞林 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190002253A—CDE ↗
盐酸高血糖素 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190002251A2023/07/05CDE ↗
胸腺五肽 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20190002232A—CDE ↗
艾塞那肽 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20170001007A2024/09/12CDE ↗
醋酸西曲瑞克 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20170000279A2022/09/27CDE ↗
醋酸阿托西班 · No verified English nameHybio Pharmaceutical Co.,Ltd.Y20170000178A2022/09/30CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

19 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
SAL0132注射液 · No verified English name CXHB2600293Supplement2026/08/12SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.; Hybio Pharmaceutical Co.,Ltd.CDE ↗
SAL0132注射液 · No verified English name CXHB2600292Supplement2026/08/12SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CYHS2601574Generic2026/07/02Zhejiang San Sheng Man Di Pharma Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CYHS2601573Generic2026/07/02Zhejiang San Sheng Man Di Pharma Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CYHS2601572Generic2026/07/02Zhejiang San Sheng Man Di Pharma Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CYHS2601571Generic2026/07/02Zhejiang San Sheng Man Di Pharma Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CYHS2601570Generic2026/07/02Zhejiang San Sheng Man Di Pharma Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600064New drug2026/05/08CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name CXHS2600063New drug2026/05/08CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD.; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400143Not stated by source2024/10/30Novo Nordisk A/S; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400142Not stated by source2024/10/30Novo Nordisk A/S; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400141Not stated by source2024/10/30Novo Nordisk A/S; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400140Not stated by source2024/10/30Novo Nordisk A/S; Hybio Pharmaceutical Co.,Ltd.CDE ↗
司美格鲁肽注射液 · No verified English name JTS2400139Not stated by source2024/10/30Novo Nordisk A/S; Hybio Pharmaceutical Co.,Ltd.CDE ↗
Cetrorelix Acetate for Injection CYHB2401522Supplement2024/09/20Hui Ling Pharmaceutical (Zhongguo) Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
注射用硫普罗宁 · No verified English name CYHB2201969Supplement2022/10/26Gansu Cheng Ji Bio Pharma Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
Cetrorelix Acetate for Injection CYHB2250301Supplement2022/05/27Hui Ling Pharmaceutical (Zhongguo) Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
Metformin Hydrochloride Extended-release Tablets CYHB2200521Supplement2022/03/18Jilin Sheng Yi Pu Bio Technology Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗
Cetrorelix Acetate for Injection CYHB2102023Supplement2021/10/21Hui Ling Pharmaceutical (Zhongguo) Co., Ltd. romanized; Hybio Pharmaceutical Co.,Ltd.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.